Loading...
4basebio PLC
88Q.DE•XETRA
Healthcare
Biotechnology
€11.00
€0.00(0.00%)
4basebio PLC (88Q.DE) Company Profile & Overview
Explore 4basebio PLC’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.
4basebio PLC (88Q.DE) Company Profile & Overview
4basebio Plc is a biotechnology company, which engages in the business of developing advanced therapy medicinal products through synthetic DNA products and non-viral, cell targeting nucleic acid delivery platforms. The firm is involved in manufacturing and supplying high quality synthetic DNA products for research, therapeutic, and pharmacological use; and developing target specific non-viral vectors for the efficient delivery of payloads in patients. The company was founded on December 22, 2020 and is headquartered in Cambridge, the United Kingdom.
SectorHealthcare
IndustryBiotechnology
CEOHeikki Lanckriet
Contact Information
25 Norman Way, Cambridge
Company Facts
101 Employees
IPO DateNov 23, 2021
CountryGB
Actively Trading